Cargando…

Current status of health technology reassessment of non-drug technologies: survey and key informant interviews

BACKGROUND: Health Technology Reassessment (HTR) is a structured, evidence-based assessment of the clinical, social, ethical and economic effects of a technology currently used in the health care system, to inform optimal use of that technology in comparison to its alternatives. Little is known abou...

Descripción completa

Detalles Bibliográficos
Autores principales: Leggett, Laura E, Mackean, Gail, Noseworthy, Tom W, Sutherland, Lloyd, Clement, Fiona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3542085/
https://www.ncbi.nlm.nih.gov/pubmed/23241276
http://dx.doi.org/10.1186/1478-4505-10-38
_version_ 1782255449382322176
author Leggett, Laura E
Mackean, Gail
Noseworthy, Tom W
Sutherland, Lloyd
Clement, Fiona
author_facet Leggett, Laura E
Mackean, Gail
Noseworthy, Tom W
Sutherland, Lloyd
Clement, Fiona
author_sort Leggett, Laura E
collection PubMed
description BACKGROUND: Health Technology Reassessment (HTR) is a structured, evidence-based assessment of the clinical, social, ethical and economic effects of a technology currently used in the health care system, to inform optimal use of that technology in comparison to its alternatives. Little is known about current international HTR practices. The objective of this research was to summarize experience-based information gathered from international experts on the development, initiation and implementation of a HTR program. METHODS: A mixed methods approach, using a survey and in-depth interviews, was adopted. The survey covered 8 concepts: prioritization/identification of potentially obsolete technologies; program development; implementation; mitigation; program championing; stakeholder engagement; monitoring; and reinvestment. Members of Health Technology Assessment International (HTAi) and the International Network of Agencies for Health Technology Assessment (INAHTA) formed the sampling frame. Participation was solicited via email and the survey was administered online using SurveyMonkey. Survey results were analyzed using descriptive statistics. To gather more in-depth knowledge, semi-structured interviews were conducted among organizations with active HTR programs. Interview questions were developed using the same 8 concepts. The hour-long interviews were recorded, transcribed and analyzed using constant comparative analysis. RESULTS: Ninety-five individuals responded to the survey: 49 were not discussing HTR, 21 were beginning to discuss HTR, nine were imminently developing a program, and 16 participants had programs and were completing reassessments. The survey results revealed that methods vary widely and that although HTR is a powerful tool, it is currently not being used to its full potential. Of the 16 with active programs, nine agreed to participate in follow-up interviews. Interview participants identified early and extensive stakeholder engagement as the most important factors for success. A lack of top-down support and financial and human resources are inhibiting program development. DISCUSSION: HTR is in its infancy. Although HTRs are being conducted, there are no standardized approaches. However, much can be learned from current international work. Future work should focus on developing a comprehensive methodology, reporting the processes of reassessments and sharing successes and challenges in a common platform.
format Online
Article
Text
id pubmed-3542085
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-35420852013-01-11 Current status of health technology reassessment of non-drug technologies: survey and key informant interviews Leggett, Laura E Mackean, Gail Noseworthy, Tom W Sutherland, Lloyd Clement, Fiona Health Res Policy Syst Research BACKGROUND: Health Technology Reassessment (HTR) is a structured, evidence-based assessment of the clinical, social, ethical and economic effects of a technology currently used in the health care system, to inform optimal use of that technology in comparison to its alternatives. Little is known about current international HTR practices. The objective of this research was to summarize experience-based information gathered from international experts on the development, initiation and implementation of a HTR program. METHODS: A mixed methods approach, using a survey and in-depth interviews, was adopted. The survey covered 8 concepts: prioritization/identification of potentially obsolete technologies; program development; implementation; mitigation; program championing; stakeholder engagement; monitoring; and reinvestment. Members of Health Technology Assessment International (HTAi) and the International Network of Agencies for Health Technology Assessment (INAHTA) formed the sampling frame. Participation was solicited via email and the survey was administered online using SurveyMonkey. Survey results were analyzed using descriptive statistics. To gather more in-depth knowledge, semi-structured interviews were conducted among organizations with active HTR programs. Interview questions were developed using the same 8 concepts. The hour-long interviews were recorded, transcribed and analyzed using constant comparative analysis. RESULTS: Ninety-five individuals responded to the survey: 49 were not discussing HTR, 21 were beginning to discuss HTR, nine were imminently developing a program, and 16 participants had programs and were completing reassessments. The survey results revealed that methods vary widely and that although HTR is a powerful tool, it is currently not being used to its full potential. Of the 16 with active programs, nine agreed to participate in follow-up interviews. Interview participants identified early and extensive stakeholder engagement as the most important factors for success. A lack of top-down support and financial and human resources are inhibiting program development. DISCUSSION: HTR is in its infancy. Although HTRs are being conducted, there are no standardized approaches. However, much can be learned from current international work. Future work should focus on developing a comprehensive methodology, reporting the processes of reassessments and sharing successes and challenges in a common platform. BioMed Central 2012-12-14 /pmc/articles/PMC3542085/ /pubmed/23241276 http://dx.doi.org/10.1186/1478-4505-10-38 Text en Copyright ©2012 Leggett et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Leggett, Laura E
Mackean, Gail
Noseworthy, Tom W
Sutherland, Lloyd
Clement, Fiona
Current status of health technology reassessment of non-drug technologies: survey and key informant interviews
title Current status of health technology reassessment of non-drug technologies: survey and key informant interviews
title_full Current status of health technology reassessment of non-drug technologies: survey and key informant interviews
title_fullStr Current status of health technology reassessment of non-drug technologies: survey and key informant interviews
title_full_unstemmed Current status of health technology reassessment of non-drug technologies: survey and key informant interviews
title_short Current status of health technology reassessment of non-drug technologies: survey and key informant interviews
title_sort current status of health technology reassessment of non-drug technologies: survey and key informant interviews
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3542085/
https://www.ncbi.nlm.nih.gov/pubmed/23241276
http://dx.doi.org/10.1186/1478-4505-10-38
work_keys_str_mv AT leggettlaurae currentstatusofhealthtechnologyreassessmentofnondrugtechnologiessurveyandkeyinformantinterviews
AT mackeangail currentstatusofhealthtechnologyreassessmentofnondrugtechnologiessurveyandkeyinformantinterviews
AT noseworthytomw currentstatusofhealthtechnologyreassessmentofnondrugtechnologiessurveyandkeyinformantinterviews
AT sutherlandlloyd currentstatusofhealthtechnologyreassessmentofnondrugtechnologiessurveyandkeyinformantinterviews
AT clementfiona currentstatusofhealthtechnologyreassessmentofnondrugtechnologiessurveyandkeyinformantinterviews